TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / Humacyte Stock

Humacyte Stock

humacyte.comHealthcare / BioTech & PharmaFounded: 2004Funding to Date: $440MM

Humacyte is the developer of a biotechnology platform designed to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine.

Buy or sell Humacyte stockLearn more about Humacyte IPO

Register To Buy and Sell Shares

For more details on financing and valuation for Humacyte, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Humacyte’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Humacyte.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Theodore Lithgow Ph.D
Chief Operating Officer
William Tente
Chief Regulatory Officer
Shannon Dahl Ph.D
Co-Founder
Jeffrey Lawson MD
President & Chief Executive Officer
Carrie Cox
Chairman & Chief Executive Officer
Laura Niklason MD
Co-Founder & Board Member
Jack Harvey
Vice President, Bioprocessing
Douglas Blankenship
Chief Financial Officer
Juliana Blum Ph.D
Co-Founder & Vice President, Business Operations & Tissue Services
Heather Prichard Ph.D
Senior Vice President of Product Development

Board Members

Brady Dougan
Credit Suisse
Laura Niklason MD
Carrie Cox
Max Wallace JD
Dale Sander
Kathleen Sebelius
Robert Anderson MD
Robert Langer Ph.D

Frequently Asked Questions About Humacyte’s Stock

plusminus
Can you buy Humacyte’s stock?
Humacyte is not publicly traded on NYSE or NASDAQ in the U.S. To buy Humacyte’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Humacyte’s stock?
Yes, you can sell stock of a private company like Humacyte. Forge can help you sell your Humacyte stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Humacyte’s stock price?
Humacyte is a privately held company and therefore does not have a public stock price. However, you may access Humacyte’s private market stock price with Forge Data.
plusminus
What is Humacyte’s stock ticker symbol?
Humacyte does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like Humacyte in the BioTech & Pharma sector

Egenesis

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$387.57MM

Colossal Biosciences

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.01B

Prime Medicine

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.23B

ADARx Pharmaceuticals

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$827.77MM

Altos Labs

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$6.33B

Tempus

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$8.7B

Cytonics

Sector
Healthcare / BioTech & Pharma
 
 

Pendulum Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$308.05MM

AI Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$110MM

Trending Companies

Frequently Asked Questions

Updated on: Apr 25, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.